Cost-effectiveness of drug treatment for young and middle-aged stage 1 hypertensive patients with high risk

BACKGROUND: Drug treatment was recommended for stage 1 hypertensive patients (blood pressure of 130-139 / 80-89 millimetres of mercury (mmHg)) with high cardiovascular disease (CVD) risk in the 2017 Hypertension Clinical Practice Guidelines, 2018 Chinese guidelines and 2021 World Health Organization...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Yan-Feng, Deng, Hua, Wang, Guo-Dong, Chen, Shuohua, Xing, Aijun, Wang, Yanxiu, Zhao, Haiyan, Gao, Jingli, Wu, Shouling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Society of Global Health 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10668205/
https://www.ncbi.nlm.nih.gov/pubmed/37997845
http://dx.doi.org/10.7189/jogh.13.04147

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10668205/
https://www.ncbi.nlm.nih.gov/pubmed/37997845
http://dx.doi.org/10.7189/jogh.13.04147

Ejemplares similares